Home - Products - Others - Other Targets - Caspase 1 Substrate 2m (ICE), fluorogenic

Caspase 1 Substrate 2m (ICE), fluorogenic

CAS No. 149231-65-2

Caspase 1 Substrate 2m (ICE), fluorogenic( ——— )

Catalog No. M41685 CAS No. 149231-65-2

Ac-YVAD-AMC is an inhibitor for caspase. Ac-YVAD-AMC inhibits bacteria-induced cell death of hypersensitive response (HR) cells.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Caspase 1 Substrate 2m (ICE), fluorogenic
  • Note
    Research use only, not for human use.
  • Brief Description
    Ac-YVAD-AMC is an inhibitor for caspase. Ac-YVAD-AMC inhibits bacteria-induced cell death of hypersensitive response (HR) cells.
  • Description
    Ac-YVAD-AMC is an inhibitor for caspase. Ac-YVAD-AMC inhibits bacteria-induced cell death of hypersensitive response (HR) cells.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    149231-65-2
  • Formula Weight
    665.7
  • Molecular Formula
    C33H39N5O10
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. del Pozo O, et al., Caspases and programmed cell death in the hypersensitive response of plants to pathogens. Curr Biol. 1998 Oct 8;8(20):1129-32.?
molnova catalog
related products
  • Atractylochromene

    Atractylochromene is an inhibitor of β-catenin dependent Wnt pathway, it may be a potential chemotherapeutic agent for the prevention and treatment of human colon cancer.

  • A-7 hydrochloride

    calmodulin antagonist

  • Bofutrelvir

    Bofutrelvir (FB2001) is a SARS-CoV-2 3CL protease inhibitor with antiviral activity for the study of novel coronavirus pneumonia (COVID-19) infections.